December 2, 2020
UC is joining a nationwide study to examine the impact of COVID-19 on communities across the United States. The Community Prevalence of SARS-CoV-2 Study (COMPASS) is part of the efforts by the COVID-19 Prevention Network launched by the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health (NIH).
December 1, 2020
Northern Kentucky businessman Carl Fox is taking part in UC's Trailblazer study and is telling his story to WCPO-TV, Channel 9. The TRAILBLAZER study aims to change the parts of a patient’s white blood cells that HIV latches onto, and is led by Dr. Carl Fichtenbaum, a professor in the Division of Infectious Diseases in the Department of Internal Medicine at the University of Cincinnati College of Medicine.
December 9, 2020
Children with epilepsy with no previous psychiatric diagnosis have alarmingly high rates of suicidal thoughts and behaviors, new research suggests. UC's Michael Privitera weighs in.
December 11, 2020
Louito Edje, MD, associate dean of medical education at the University of Cincinnati College of Medicine and UC Medical Center, speaks with CNBC about her participation in a Phase 3 clinical trial for SARS-CoV-2 vaccine after three of her relatives died from the coronavirus. UC is one of approximately 90 sites in the country to host a trial for the mRNA-1273 vaccine developed by the National Institute of Allergy and Infectious Diseases scientists and collaborators at biotechnology company Moderna.
December 11, 2020
Matthew de Gannes is one of 38 students in the College of Medicine who will earn degrees during the virtual 2020 fall commencement ceremonies set for Dec. 11 and 12. The college will grant 14 doctoral, 23 master’s and one bachelor’s degree. UC is awarding a total of 2,457 degrees to 2,348 students during fall commencement. Some UC programs allow students to earn dual degrees.
December 10, 2020
Dustin Calhoun, MD, of the Department of Emergency Medicine in the UC College of Medicine, was interviewed by the Wall Street Journal about how the rollout of COVID-19 vaccines would work.
December 4, 2020
UC researchers are seeking participants in a study for an opioid addiction treatment that could weaken withdrawal symptoms and increase the likelihood of recovery for pregnant women.
December 7, 2020
The Collaboration Network hosted a virtual conference on Racial and Health Inequities Exposed by COVID-19 Thursday, November 19 from 9 a.m. to 11 a.m. Andrew Beck, MD, a Cincinnati Children’s physician and associate professor of pediatrics at the University of Cincinnati, and Karen Bankston, PhD, professor of emerita of the UC College of Nursing, were among those who discussed and presented regional data about COVID-19’s disproportionate impact on communities of color in Greater Cincinnati.
December 15, 2020
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases was interviewed by POPSUGAR for a story on whether people who have had the COVID-19 virus should get the vaccine.
December 16, 2020
Ahmad R. Sedaghat, MD, PhD, director of the division of rhinology, allergy, and anterior skull base surgery at the University of Cincinnati College of Medicine, told ENT Today that because COVID-19 is a viral infection, patients may experience more severe body aches, lethargy, and fatigue compared to a bacterial sinus infection.